NCT03074513 2026-03-11Atezolizumab and Bevacizumab in Treating Patients With Rare Solid TumorsM.D. Anderson Cancer CenterPhase 2 Active not recruiting133 enrolled
NCT06683846 2025-08-24Ivonescimab in the Treatment of Multiple Advanced TumorsFudan UniversityPhase 2 Recruiting400 enrolled
NCT03858855 2020-08-04Inhaled Essential Oil Effect on Common QOL Concerns During Cancer TreatmentOhio State University Comprehensive Cancer CenterPhase NA Completed248 enrolled
NCT00004922 2013-06-19Irinotecan in Treating Patients With Advanced Neuroendocrine TumorsMemorial Sloan Kettering Cancer CenterPhase 2 Completed